Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This blinded, placebo-controlled study will administer inhaled nitric oxide to patients
undergoing liver transplantation. The purpose of the study is to test if inhaled nitric oxide
prevents liver injury associated with the restoration of blood flow. The premise of the
current study is provided by previous studies which document a protective effect of inhaled
nitric oxide in this clinical setting.